Abstract
NO generation in the course of two acute, non immune, inflammatory reactions (pleurisy induced by rat isologous serum and carrageenan) was assessed by means of nitrite measurement in pleural exudate from 0.5 to 24 h. NO release varied time-dependently, similarly for the two inflammatory reactions. A first, but transient, peak was reached in 30 min while a second peak, more sustained, began at the fourth hour and was maximum at the tenth. Kinetic evolution of NO release was consistent with activation, in a first step, of a constitutive NO synthase probably from endothelial origin (inhibited by 2-Methyl-2-Thiopseudourea sulfate but not by dexamethasone) and with activation, in a second wave, of inducible NOS from endothelial and exudative cells. NO release was potentiated by administration per os of L-Arginine and seems to be involved in the evolution of acute inflammatory reactions and oxygen metabolite production.
Similar content being viewed by others
References
Aoki, E., I. K. Takeuchi, andR. Shoji. 1995. Nitric oxide: An attractive signaling molecule.Acta Histochem. Cytochem. 28:97–106.
Kerwin, J. F., J. R. Lancaster, andP. L. Feldman. 1995. Nitric oxide: A new paradigm for second messengers.J. Med. Chem. 38:4343–4362.
Palmer, R. M. J., A. G. Ferrige, andS. Moncada. 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.Nature 327:524–527.
Snyder, S. H. 1992. Nitric oxide: First in a new class of neurotransmitters?Science 257:494–496.
Nussler, A. K., andT. R. Billiar. 1993. Inflammation, immunoregulation and inducible nitric oxide synthase.J. Leuk. Biol. 54:171–178.
Hibbs, J. B., R. R. Taintor, Z. Vavrin, andE. M. Rachlin. 1988. Nitric oxide: a cytotoxic activated macrophage effector molecule.Biochem. Biophys. Res. Commun. 157:87–94.
Moncada, S., andA. Higgs. 1993. Mechanisms of disease: the L-arginine-nitric oxide pathway.N. Engl. J. Med. 329:2002–2012.
Clancy, R. M., andS. B. Abramson. 1995. Nitric oxide: A novel mediator of inflammation (Minireview).Proc. Soc. Exp. Biol. Med. 210:93–101.
Baquial, J. G. L., andJ. R. J. Sorenson. 1995. Down regulation of NADPH-Diaphorase (Nitric oxide synthase) may account for the pharmacological activities of Cu(II)2 (3,5-Diisopropylsalicylate)4.J. Inorg. Biochem. 60:133–148.
Kostka, P. 1995. Free radicals (Nitric oxide)Analytic Chem. 67:411R-416R.
Hope, B. T., G. J. Michael, K. M. Knigge, andS. R. Vincent. 1991. Neuronal NADPH diaphorase is a nitric oxide synthase.Proc. Natl. Acad. Sci. U.S.A. 88:2811–2814.
Ghosh, D. K., H. M. Abu-Soud, andD. J. Stuehr. 1995. Reconstitution of the second step in NO synthesis using the isolated oxygenase and reductase domains of macrophage NOsynthase.Biochem. 34:11316–11320.
Hobbs, A. J., J. M. Fukuto, andL. J. Ignarro. 1994. Formation of free nitric oxide from L-arginine by nitric oxide synthase: Direct enhancement of generation by superoxide dismutase.Proc. Natl. Acad. Sci. U.S.A. 91:10992–10996.
Inoue, S., S. Kawanishi. 1995. Oxidative DNA damage induced by simultaneous generation of nitric oxide and superoxide.FEBS Lett. 371:86–88.
Rodenas, J., M. T. Mitjavila, andT. Carbonell. 1995. Simultaneous generation of nitric oxide and superoxide by inflammatory cells in rats.Free Rad. Biol. Med. 18:869–875.
McCord, J. M., andI. Fridovitch. 1969. Superoxide dismutase. An enzymatic function for erythrocuprein (Hemocuprein).J. Biol. Chem. 244:6049–6055.
Regnault, C., C. Benoist, H. Fessi, M. Roch-Arveiller, E. Postaire, andG. Hazebroucq. 1996. Preparation of superoxide dismutase entrapped in ceramide-containing liposomes for oral administration.Int. J. Pharmaceut. 132:263–266.
Regnault, C., M. Soursac, M. Roch-Arveiller, E. Postaire, andG. Hazebroucq. 1996. Pharmacokinetics of Superoxide Dismutase in rat after oral administrationBiopharm. Drug Dispos. 17:165–174.
Giroud, J. P., M. Roch-Arveiller, andO. Muntaner. 1978. Prélèvement répété des polynucléaires dans la cavité pleurale du rat. Application à la mesure du chimiotactisme.Nelle. Rev. Fse. Hematol. 20:535–543.
Roch-Arveiller, M., C. J. Dunn, andJ. P. Giroud. 1977. Comparaison des propriétés inflammatoires des fractionsδ andκ de carragénine.J. Pharmacol. 8:461–476.
Marletta, M. A., P. S. Yoon, R. Iyengar, C. D. Leaf, andJ. S. Wishnok. 1988. Macrophage oxidation of L-arginine to nitrite and nitrate: Nitric oxide is an intermediate.Biochem. 27:8706–8711.
McCall, T. B., R. M. J. Palmer, andS. Moncada. 1991. Induction of nitric oxide synthase in rat peritoneal neutrophils and its inhibition by dexamethasone.Eur. J. Immunol. 21:2523–2527.
Southan, G. J., C. Szabo, andC. Thiemermann. 1995. Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity.Br. J. Pharmacol. 114:510–514.
Farrell, A. J., D. R. Blake, R. M. J. Palmer, andS. Moncada. 1992. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases.Ann. Rheum. Dis. 51:1219–1221.
Stefanovic-Racic, M., J. Stadler, C. H. Evans. 1993. Nitric oxide and arthritis.Arthritis Rheum. 36:1036–1044.
Tissot, M., C. Bonne, B. Martin, M. Solier, andJ. P. Giroud. 1984. Prostacyclin and thromboxanes in carrageenan-induced pleurisy in the rat.Agents and Actions. 14:76–81.
Tissot, M., D. Regoli, andJ. P. Giroud. 1985. Bradykinin levels in inflammatory exudates.Inflammation 9:419–424.
Palmer, R. M. J., A. G. Ferrige, andS. Moncada. 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.Nature 327:524.
Ialenti, A., A. Ianaro, S. Moncada, andM. Di Rosa. 1992. Modulation of acute inflammation by endogenous nitric oxide.Eur. J. Pharmacol. 211:177–182.
Radomski, M. W., R. M. J. Palmer, andS. Moncada. 1990. Glucocorticoids inhibit the expression of an inducible but not the constitutive nitric oxide synthase in vascular endothelial cells.Proc. Natl. Acad. Sci. U.S.A. 87:10043–10045.
Snyder, S. H. 1994. Nitric oxide: More job for that molecule.Nature 372:504–505.
De Caterina, R., P. Libby, H. B. Peng, V. J. Thannickal, T. B. Rajavashisth, M. A. Gimbrone, W. S. Shin, J. K. Liao. 1995. Nitric oxide decreases cytokine-induced endothelial activation.J. Clin. Invest. 96:60–68.
Stamler, J. S., D. J. Singel, andJ. Loscalzo. 1992. Biochemistry of nitric oxide and its redox-activated forms.Science 258:1898–1902.
Robbins, R. A., D. R. Springall, J. B. Warren, O. J. Kwon, L. D. K. Buttery, A. J. Wilson, I. M. Adcock, V. Riveros-Moreno, S. Moncada, J. Polak, andP. J. Barnes. 1994. Inducible nitric oxide synthase is increased in murine lung epithelial cells by cytokine stimulation.Biochem. Biophys. Res. Commun. 198:835–843.
Deakin, A. M., A. N. Payne, B. J. R. Whittle, andS. Moncada. 1995. The modulation of IL-6 and TNF-α release by nitric oxide following stimulation of J-774 cells with LPS and INF-7.Cytokine 7:408–416.
Huie, R. E., andS. Padmaja. 1993. The reaction of NO with superoxide.Free Rad. Res. Comms. 18:195–199.
Meng, Y. Y., J. Trachtenburg, U. S. Ryan, andD. R. Abendschein. 1995. Potentiation of endogenous nitric oxide with superoxide dismutase inhibits platelet-mediated thrombosis in injured and stenotic arteries.J. Am. Coll. Cardiol. 25:269–275.
Regnault, C., M. Roch-Arveiller, M. Tissot, G. Sarfati, J. P. Giroud, E. Postaire, andG. Hazebroucq. 1995. Effect of encapsulation on the anti-inflammatory properties of superoxide dismutase after oral administration.Clin. Chim. Acta 240:117–127.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Regnault, C., Roch-Arveiller, M., Florentin, I. et al. Kinetic evaluation of nitric oxide production in pleural exudate after induction of two inflammatory reactions in the rat. Inflammation 20, 613–622 (1996). https://doi.org/10.1007/BF01488799
Issue Date:
DOI: https://doi.org/10.1007/BF01488799